Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.
Biviano
Angelo B
AB
Department of Internal Medicine, College of Physicians and Surgeons of Columbia University, and New York Presbyterian Hospital, New York, New York 10032, USA.
Rabbani
LeRoy E
LE
Paultre
Furcy
F
Hurley
Eileen
E
Sullivan
Jennifer
J
Giglio
James
J
Mosca
Lori
L
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy / Q000517:prevention & control*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D003325:Coronary Care Units / Q000592:standards*; D019091:Critical Pathways; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control*; D010349:Patient Compliance; D010353:Patient Education as Topic; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D015397:Program Evaluation; D012189:Retrospective Studies
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin